Abstract
Women at risk for sudden cardiac death (SCD) are often underrepresented in defibrillator trials and outcomes surrounding ventricular arrhythmias (VA) are therefore not well studied. The wearable-cardioverter defibrillator (WCD) is an effective short-term therapy and serves as a diagnostic tool to
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
